Breakthrough brings potential glioblastoma drug into focus
byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T
Updated on: January 07,2024
Breakthrough brings potential glioblastoma drug into focus
byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T
Updated on:January 07,2024
